Merck KGaA (OTCMKTS:MKKGY) Sets New 52-Week Low – What’s Next?

Merck KGaA (OTCMKTS:MKKGY)’s stock price hit a new 52-week low during trading on Wednesday . The stock traded as low as $27.19 and last traded at $27.23, with a volume of 47833 shares trading hands. The stock had previously closed at $28.26.

Merck KGaA Trading Down 3.6 %

The firm has a fifty day moving average of $29.22 and a 200 day moving average of $31.10. The firm has a market capitalization of $17.60 billion, a PE ratio of 16.81, a P/E/G ratio of 2.05 and a beta of 0.98. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33.

Merck KGaA (OTCMKTS:MKKGY) last posted its quarterly earnings data on Thursday, March 6th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07. The company had revenue of $5.78 billion for the quarter, compared to analyst estimates of $5.40 billion. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. Equities research analysts expect that Merck KGaA will post 1.87 EPS for the current year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.